[Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate]
F Bange1, M-F Le Heuzey1, E Acquaviva1
1Service de psychiatrie de l'enfant et de l'adolescent, hôpital Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France.
Methylphenidate, used for Attention Deficit Hyperactivity Disorder (ADHD), shows no increased short-term cardiovascular risk in children. However, long-term effects and underlying heart conditions require further research for safe stimulant use.
Area of Science:
- Neuroscience
- Pediatric Medicine
- Cardiology
Context:
- Attention Deficit Hyperactivity Disorder (ADHD) is a common pediatric neuropsychiatric disorder.
- Methylphenidate is a primary therapeutic agent for ADHD.
- Concerns exist regarding the cardiovascular safety of methylphenidate due to its stimulant effects.
Purpose:
- To evaluate the cardiovascular safety of methylphenidate in children with ADHD.
- To review current evidence and identify knowledge gaps regarding methylphenidate's cardiac effects.
- To provide clinical guidance on pre-treatment evaluation and cardiovascular assessment for methylphenidate use.
Summary:
- Recent large cohort studies indicate methylphenidate is not associated with increased short- or mid-term risks of myocardial infarction, sudden cardiac death, or stroke.
- Despite reassuring data, long-term effects of sustained heart rate and blood pressure increases remain unknown.
- Further research is needed to fully understand the cardiovascular implications, especially in children with pre-existing heart abnormalities.
Impact:
- Provides clinicians with updated safety information on methylphenidate for ADHD treatment.
- Highlights the need for thorough pre-treatment cardiovascular screening, including ECG in certain cases.
- Emphasizes ongoing research to ensure the safe and effective use of methylphenidate in pediatric populations.
More Related Videos
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Atherosclerosis III: Management
Hypertension V: Nursing Management
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
